SAN DIEGO, March 29, 2023 (GLOBE NEWSWIRE) — Shareholder law firm Johnson Fistel, LLP is investigating possible violations of law related to the following special purpose acquisition entities (“SPACs”):

Pardes Biosciences, Inc. w/k/a FS Development Corp PRDS
Gemini Therapeutics w/k/a FS Development Corp., GMTX
Vacasa, Inc. w/k/a TPG Pace Solutions Corp. VCSA
Advent Technologies Holdings, Inc. w/k/a AMCI Acquisition Corp ADN.

If you are an investor who has suffered losses related to any of the SPACs purchased below: Click on the following web address or paste it into your browser to submit your losses:

Vacasa, Inc. w/k/a TPG Pace Solutions Corp. VCSA:
https://www.johnsonfistel.com/investigations/strongvacasa-inc-strong-fka-tpg-pace-solutions

Pardes Biosciences, Inc. f/k/a FS Development Corp PRDS:
https://www.johnsonfistel.com/investigations/pardes-biosciences-inc-fs-development

Gemini Therapeutics w/k/a FS Development Corp. GMTX:
https://www.cognitoforms.com/JohnsonFistel/GeminiTherapeuticsFkaFSDevelopmentCorp

Advent Technologies Holdings, Inc. f/k/a AMCI Acquisition Corp ADN:
https://www.cognitoforms.com/JohnsonFistel/Advent Technologies Holdings IncFkaAMCIAcquisitionCorp2

Or contact Jim Baker at for more information jimb@johnsonfistula.com or (619) 814-4471

About Johnson Fistula, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in class action lawsuits involving shareholder derivatives and securities. Johnson Fistula seeks to recover losses incurred as a result of violations of federal securities laws. For more information about the firm and its attorneys, visit http://www.johnsonfistula.com. attorney advertising. Past results do not guarantee future results.

Contact:
Johnson Fistula, LLP
jim baker, 619-814-4471
Investor Relations
jimb@johnsonfistula.com